TY - JOUR T1 - COVI-Prim survey: Challenges for Austrian and German general practitioners during initial phase of COVID-19 JF - medRxiv DO - 10.1101/2020.11.24.20237743 SP - 2020.11.24.20237743 AU - Andrea Siebenhofer AU - Sebastian Huter AU - Alexander Avian AU - Karola Mergenthal AU - Dagmar Schaffler-Schaden AU - Ulrike Spary-Kainz AU - Herbert Bachler AU - Maria Flamm Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/24/2020.11.24.20237743.abstract N2 - Background Coronavirus disease 2019 (COVID-19) represents a significant challenge to health care systems around the world. A well-functioning primary care system is crucial in epidemic situations as it plays an important role in the development of a system-wide response.Methods 2,187 Austrian and German GPs answered an internet suvey on preparedness, testing, staff protection, perception of risk, self-confidence, a decrease in the number of patient contacts, and efforts to control the spread of the virus in the practice during the early phase of the COVID-pandemic (3rd to 30th April).Results The completion rate of the questionnaire was high (90.9%). GPs gave low ratings to their preparedness for a pandemic, testing of suspected cases and efforts to protect staff. The provision of information to GPs and the perception of risk were rated as moderate. On the other hand, the participants rated their self-confidence, a decrease in patient contacts and their efforts to control the spread of the disease highly.Conclusion Primary care is an important resource for dealing with a pandemic like COVID-19. The workforce is confident and willing to take an active role, but needs to be provided with the appropriate surrounding conditions. This will require that certain conditions are met.Registration Trial registration at the German Clinical Trials Register: DRKS00021231Primary Funding Source The study was financed by the cooperating University Institutes without any external financial support.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol has been approved by the local ethics committee of Goethe University Frankfurt, Germany (20-619).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors have uploaded an additional minimal data set to Data Archiving and Networked Services (DANS) https://doi.org/10.17026/dans-z8u-unbv ER -